======= MYLK2 ======= == Gene Information == * **Official Symbol**: MYLK2 * **Official Name**: myosin light chain kinase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=85366|85366]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H1R3|Q9H1R3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MYLK2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MYLK2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606566|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a myosin light chain kinase, a calcium/calmodulin dependent enzyme, that is exclusively expressed in adult skeletal muscle. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N- terminus of a myosin light chain. {ECO:0000269|PubMed:11733062}. |Pkinase Tyr| |Pkinase| |regulation of muscle filament sliding| |myosin light chain kinase activity| |skeletal muscle satellite cell differentiation| |myosin light chain binding| |calmodulin-dependent protein kinase activity| |neuromuscular synaptic transmission| |regulation of actin filament-based movement| |sarcomere| |skeletal muscle cell differentiation| |cardiac muscle tissue morphogenesis| |cardiac muscle contraction| |muscle tissue morphogenesis| |peptidyl-threonine phosphorylation| |heart contraction| |muscle organ morphogenesis| |peptidyl-threonine modification| |heart process| |striated muscle contraction| |skeletal muscle tissue development| |skeletal muscle organ development| |regulation of muscle contraction| |cardiac muscle tissue development| |protein autophosphorylation| |calmodulin binding| |regulation of muscle system process| |heart morphogenesis| |muscle contraction| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |muscle system process| |regulation of intracellular transport| |regulation of actin filament-based process| |blood circulation| |circulatory system process| |anterograde trans-synaptic signaling| |chemical synaptic transmission| |trans-synaptic signaling| |synaptic signaling| |muscle structure development| |heart development| |tissue morphogenesis| |regulation of system process| |circulatory system development| |peptidyl-amino acid modification| |regulation of cellular localization| |animal organ morphogenesis| |protein phosphorylation| |regulation of cellular component movement| |cell-cell signaling| |phosphorylation| |ATP binding| |tissue development| |regulation of transport| |system process| |positive regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.96| |[[:results:exp392|PT-1 25μM R07 exp392]]|1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3829 * **Expression level (log2 read counts)**: 0.63 {{:chemogenomics:nalm6 dist.png?nolink |}}